0001209191-15-059834.txt : 20150706 0001209191-15-059834.hdr.sgml : 20150703 20150706203623 ACCESSION NUMBER: 0001209191-15-059834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150706 DATE AS OF CHANGE: 20150706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINGSLEY ALFRED D CENTRAL INDEX KEY: 0001229339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 15975041 MAIL ADDRESS: STREET 1: 150 E 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-07-01 0 0000876343 BIOTIME INC BTX 0001229339 KINGSLEY ALFRED D 150 E. 57TH STREET NEW YORK NY 10022 1 1 1 0 See Remarks Common Shares, no par value 6038055 D Common Shares, no par value 1506905 I By Greenbelt Corp. Common Shares, no par value 375351 I By Greenway Partners, LP Option to Purchase Common Shares 3.57 2015-07-01 4 A 0 50000 0.00 A 2020-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 3.11 2019-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 4.13 2018-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 4.60 2017-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 5.13 2016-06-30 Common Shares 50000 50000 D Option to Purchase Common Shares 5.45 2015-08-09 Common Shares 50000 50000 D Does not include shares that Mr. Kingsley may acquire through the exercise of certain options. Will become exercisable in four equal quarterly installments based upon continued service on the board of directors. Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014. 12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014. 12,500 options became exercisable on September 30, 2012; December 31, 2012; March 31, 2013; and June 30, 2013. 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012. 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011. Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries. /s/ Alfred D. Kingsley 2015-07-06